REDUCEDT+2
Kumar Neil
Bridgebio Pharma Inc · NASDAQ
−1,900 sh · $154.2K
Filed 20 Aug 2026SEC Form 4view source
Viking Global Investors
13F filer
$741.0M
9,949,219 sh
Two Sigma Investments
13F filer
$353.4M
4,745,285 sh
BlackRock
13F filer
$315.3M
12,448,272 sh
Bridgewater Associates
13F filer
$33.4M
448,143 sh
Renaissance Technologies
13F filer
$27.2M
365,772 sh
Polen Capital Management
13F filer
$3.4M
45,934 sh
Kumar Neil
Bridgebio Pharma Inc · NASDAQ
−1,900 sh · $154.2K
Kumar Neil
Bridgebio Pharma Inc · NASDAQ
−1,800 sh · $152.4K
Kumar Neil
Bridgebio Pharma Inc · NASDAQ
−14,602 sh · $1.2M
Kumar Neil
Bridgebio Pharma Inc · NASDAQ
−1,199 sh · $100.4K
Kumar Neil
Bridgebio Pharma Inc · NASDAQ
−17,279 sh · $1.4M
Kumar Neil
Bridgebio Pharma Inc · NASDAQ
−100 sh · $8.6K
Kumar Neil
Bridgebio Pharma Inc · NASDAQ
−8,100 sh · $679.3K
Two Sigma Investments
Bridgebio Pharma Inc · NASDAQ
4,745,285 sh · $353.4M
Viking Global Investors
Bridgebio Pharma Inc · NASDAQ
9,949,219 sh · $741.0M
Bridgewater Associates
Bridgebio Pharma Inc · NASDAQ
448,143 sh · $33.4M